A Therapeutic Opportunity in Melanoma: ErbB4 Makes a Mark on Skin

13Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

Abstract

Malignant melanomas are aggressive tumors that are largely refractory to conventional drug therapies. A recent study reported in Nature Genetics identified mutationally activated ErbB4 alleles in 20% of cases. These tumor cells exhibit ErbB4 dependency, suggesting that ErbB4 kinase inhibition may constitute an effective therapeutic strategy in this setting. © 2009 Elsevier Inc. All rights reserved.

Cite

CITATION STYLE

APA

Settleman, J. (2009, October 6). A Therapeutic Opportunity in Melanoma: ErbB4 Makes a Mark on Skin. Cancer Cell. https://doi.org/10.1016/j.ccr.2009.09.013

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free